Levilactobacillus brevis
Lactobacillus brevis · L. brevis
Snapshot
| Indications | Contraindications |
|---|---|
Levilactobacillus brevis (formerly Lactobacillus brevis) is a lactic acid bacterium found in fermented foods such as kimchi. As a probiotic it is thought to act by modulating oral microbial communities and local inflammatory signaling.1 People use it mainly for oral health, including gingival bleeding and mucositis during cancer treatment. Other uses are vaginal health, influenza prevention in children, and stress.
Oral mucositis evidence is split: a randomized trial in head and neck cancer found less severe mucositis with one strain's lozenges, while a later multicentre trial found no difference. As a periodontitis adjunct, one trial found less gingival bleeding but more persisting deep sites. A 2025 mini review of non-pharmacological options for estrogen decline reported that a probiotic maintained circulating estrogens in peri- and postmenopausal women over 12 weeks, while levels fell on placebo9. There are 77 products listing Levilactobacillus brevis, mostly capsules, while the oral trials used lozenges; see Form comparison.
Effects are strain-specific, so results for one strain do not transfer to another.8 United States product labels warn against use in pregnancy or nursing on 2 of 30 labels, and most others ask for a healthcare professional's advice first8.
Last updated October 17, 2026. Read how we make monographs.
In the full monograph
41 sources, 36 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults.pubmed.ncbi.nlm.nih.govAltamura, Lombardi, Augello et al. · Journal of translational medicine · 2025 · Pubmed
- 2Modulation of the host response by probiotic Lactobacillus brevis CD2 in experimental gingivitis.pubmed.ncbi.nlm.nih.govLee, Kim, Ko et al. · Oral diseases · 2015 · Pubmed
- 3Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.pubmed.ncbi.nlm.nih.govSharma, Rath, Chaudhary et al. · European journal of cancer (Oxford, England : 1990) · 2012 · Pubmed
- 4Effectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: a randomized, double-blind study.pubmed.ncbi.nlm.nih.govHemalatha, Mastromarino, Ramalaxmi et al. · European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012 · Pubmed
- 5Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: an open-label pilot study.pubmed.ncbi.nlm.nih.govWaki, Matsumoto, Fukui et al. · Letters in applied microbiology · 2014 · Pubmed
- 6Effect of the Intake of a Traditional Mexican Beverage Fermented with Lactic Acid Bacteria on Academic Stress in Medical Students.pubmed.ncbi.nlm.nih.govMárquez-Morales, El-Kassis, Cavazos-Arroyo et al. · Nutrients · 2021 · Pubmed
- 7Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study.pubmed.ncbi.nlm.nih.govMohseni, Taghinezhad-S, Keyvani et al. · Probiotics and antimicrobial proteins · 2018 · Pubmed
- 8US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 9Natural strategies to optimize estrogen levels in aging women: mini review.pubmed.ncbi.nlm.nih.govBolgova, Shypilova, Mavrych · Frontiers in aging · 2025 · Pubmed